Efficacy evaluation and potential pharmacological mechanism of tanreqing injection in the treatment of COPD combined with respiratory failure based on meta-analysis and network pharmacology

[1]  Yuzong Chen,et al.  Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents , 2021, Nucleic Acids Res..

[2]  Xianmei Zhou,et al.  Chinese herbal medicine for symptoms of depression and anxiety in chronic obstructive pulmonary disease: A systematic review and meta-analysis. , 2021, Complementary therapies in clinical practice.

[3]  Kaixian Chen,et al.  Systematic investigation of the pharmacological mechanism of Tanreqing injection in treating respiratory diseases by UHPLC/Q-TOF-MS/MS based on multiple in-house chemical libraries coupled with network pharmacology. , 2021, Journal of pharmaceutical and biomedical analysis.

[4]  Yujie Huang,et al.  Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway. , 2021, Pulmonary pharmacology & therapeutics.

[5]  P. Godoy,et al.  Clinico-epidemiological characteristics of men and women with a new diagnosis of chronic obstructive pulmonary disease: a database (SIDIAP) study , 2021, BMC Pulmonary Medicine.

[6]  P. Zhao,et al.  A chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[7]  Md. Tarek Hossain,et al.  Prevalence, risk factors, and interventions for chronic obstructive pulmonary disease in South Asia: a scoping review protocol , 2021, Systematic Reviews.

[8]  M. Young,et al.  Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 2020 .

[9]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[10]  F. Martinez,et al.  Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease , 2020, American journal of respiratory and critical care medicine.

[11]  K. Gaede,et al.  Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysis , 2020, PloS one.

[12]  I. Batyrshin,et al.  Relationship of Serum Levels of IL-17, IL-18, TNF-α, and Lung Function Parameters in Patients with COPD, Asthma-COPD Overlap, and Bronchial Asthma , 2020, Mediators of inflammation.

[13]  Yong Wang,et al.  Feikang granules ameliorate pulmonary inflammation in the rat model of chronic obstructive pulmonary disease via TLR2/4-mediated NF-κB pathway , 2020, BMC Complementary Medicine and Therapies.

[14]  Meilan K. Han,et al.  Goals of COPD treatment: Focus on symptoms and exacerbations. , 2020, Respiratory medicine.

[15]  F. Yıldız.  The Efficacy of Lung Volume Reduction Coil Treatment in Patients with Severe Chronic Obstructive Pulmonary Disease (COPD) Type II Respiratory Failure , 2020, International journal of chronic obstructive pulmonary disease.

[16]  K. Tsaneva-Atanasova,et al.  'HIGH RISK' CLINICAL AND INFLAMMATORY CLUSTERS IN COPD OF CHINESE DESCENT. , 2020, Chest.

[17]  F. Sanz,et al.  The DisGeNET knowledge platform for disease genomics: 2019 update , 2019, Nucleic Acids Res..

[18]  Xia-Wei Zhang,et al.  Systems pharmacology-based study of Tanreqing injection in airway mucus hypersecretion. , 2019, Journal of ethnopharmacology.

[19]  E. Garpestad,et al.  Noninvasive Ventilatory Support for Acute Hypercapnic Respiratory Failure , 2019, Respiratory Care.

[20]  S. Duan,et al.  Simultaneous determination of seven flavonoids, two phenolic acids and two cholesterines in Tanreqing injection by UHPLC‐MS/MS , 2019, Journal of pharmaceutical and biomedical analysis.

[21]  Wen Chen,et al.  Disease burden of COPD in China: a systematic review , 2018, International journal of chronic obstructive pulmonary disease.

[22]  M. Miravitlles,et al.  Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research – a consensus document from six scientific societies , 2017, International journal of chronic obstructive pulmonary disease.

[23]  P. Barnes.  Cellular and molecular mechanisms of asthma and COPD. , 2017, Clinical science.

[24]  W. Zhou,et al.  TP53-dependent autophagy links the ATR-CHEK1 axis activation to proinflammatory VEGFA production in human bronchial epithelial cells exposed to fine particulate matter (PM2.5) , 2016, Autophagy.

[25]  Tsippi Iny Stein,et al.  The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses , 2016, Current protocols in bioinformatics.

[26]  N. Hansel,et al.  Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management , 2015, Seminars in Respiratory and Critical Care Medicine.

[27]  Egon L. Willighagen,et al.  PubChemRDF: towards the semantic annotation of PubChem compound and substance databases , 2015, Journal of Cheminformatics.

[28]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[29]  Olivier Michielin,et al.  Shaping the interaction landscape of bioactive molecules , 2013, Bioinform..

[30]  B. Mao,et al.  Effect of Tanreqing Injection (痰热清注射液) on treatment of acute exacerbation of chronic obstructive pulmonary disease with Chinese medicine syndrome of retention of phlegm and heat in Fei (肺) , 2010, Chinese journal of integrative medicine.

[31]  Y. Xun.  Effect Observation of Tanreqing Injection on Treating Respiratory Failure in Acute Exacerbation of Chronic Obstructive Pulmonary Dvsease , 2008 .

[32]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[33]  J. Rees.  Prevalence , 2005, BMJ : British Medical Journal.